Home / About us / Leadership / Lianne Baker, BSc, BEd
Lianne Baker, BSc, BEd
Senior Facilities & Procurement Manager
Lianne holds a Bachelor of Science in Biology from Dalhousie University and a Bachelor of Education from Mount Saint Vincent University. Her diverse educational background combines scientific knowledge with strong communication, organization, and instructional skills.
Prior to joining AGADA, Lianne worked as an Assistant Buyer, Administrative Officer, and secondary school teacher. Through these roles, she developed expertise in project coordination, administration, procurement support, and stakeholder communication, bringing a well-rounded perspective and strong organizational skills to her work.
Lianne manages AGADA’s facilities, laboratory infrastructure, and purchasing, keeping all our operations safe and compliant. She also runs the company’s sourcing and vendor management programs, handles facility maintenance and leads capital planning to upgrade laboratory environments as the business grows.
Get in touch
To learn how AGADA Biosciences could support your program, get in touch with our team and start the conversation.
How we work
We bring an agile, collaborative and responsive approach to every engagement, shaping our support around the needs of your program rather than a rigid process. Whether you engage us at a single stage or across multiple points in development, we work to de-risk programs, protect data integrity and help your teams progress with confidence.
1
Refined for your program:
We shape our approach around the needs of each program, not the other way around.
2
Direct access to senior experts:
Our lean model keeps scientific expertise close to the work and communication clear.
3
Built to de-risk progress:
We help you de-risk development through rigorous science and practical support.
4
Protecting data integrity:
Our work is designed to support reliable outputs and maintain confidence in the data.
Why AGADA?
We bring dedicated expertise to programs where there is little room for error, providing the scientific support, responsiveness and program fit that help rare disease teams move forward with clarity.
Decade of specialization:
Founded in 2013 as a spinout from Children’s National Medical Center to provide specialist scientific support for rare disease drug development.
Consistent audit success:
We successfully pass an average of five sponsor audits annually to support clinical trials across multiple phases.
Historical benchmarking:
We leverage archival data from over 100 trials in mouse models of muscular dystrophy to accurately power your efficacy studies.
Dedicated scale:
We operate with a team of approximately 50 employees, entirely focused on executing complex rare disease programs.
Meet more of the leadership team
